PubMed

Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. A randomized, controlled trial.

Grey AB, Stapleton JP, Evans MC, Tatnell MA, Reid IR.

Ann Intern Med. 1996 Sep 1;125(5):360-8.PMID: 8702086 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of hormone replacement therapy on bone mineral density in postmenopausal women with primary hyperparathyroidism: four-year follow-up and comparison with healthy postmenopausal women.

Orr-Walker BJ, Evans MC, Clearwater JM, Horne A, Grey AB, Reid IR.

Arch Intern Med. 2000 Jul 24;160(14):2161-6.PMID: 10904459 [PubMed - indexed for MEDLINE]Related articlesFree article

Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss.

Gallagher JC, Fowler SE, Detter JR, Sherman SS.

J Clin Endocrinol Metab. 2001 Aug;86(8):3618-28.PMID: 11502787 [PubMed - indexed for MEDLINE]Related articlesFree article

Alveolar and postcranial bone density in postmenopausal women receiving hormone/estrogen replacement therapy: a randomized, double-blind, placebo-controlled trial.

Civitelli R, Pilgram TK, Dotson M, Muckerman J, Lewandowski N, Armamento-Villareal R, Yokoyama-Crothers N, Kardaris EE, Hauser J, Cohen S, Hildebolt CF.

Arch Intern Med. 2002 Jun 24;162(12):1409-15. Erratum in: Arch Intern Med. 2004 Jan 12;164(1):96. PMID: 12076241 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen.

Gallagher JC, Kable WT, Goldgar D.

Am J Med. 1991 Feb;90(2):171-8.PMID: 1847582 [PubMed - indexed for MEDLINE]Related articles

Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women.

Lindsay R, Gallagher JC, Kleerekoper M, Pickar JH.

JAMA. 2002 May 22-29;287(20):2668-76.PMID: 12020302 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. The Writing Group for the PEPI.

[No authors listed]

JAMA. 1996 Nov 6;276(17):1389-96.PMID: 8892713 [PubMed - indexed for MEDLINE]Related articles

Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.

Cauley JA, Robbins J, Chen Z, Cummings SR, Jackson RD, LaCroix AZ, LeBoff M, Lewis CE, McGowan J, Neuner J, Pettinger M, Stefanick ML, Wactawski-Wende J, Watts NB; Women's Health Initiative Investigators.

JAMA. 2003 Oct 1;290(13):1729-38.PMID: 14519707 [PubMed - indexed for MEDLINE]Related articlesFree article

Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial.

Khan AA, Bilezikian JP, Kung AW, Ahmed MM, Dubois SJ, Ho AY, Schussheim D, Rubin MR, Shaikh AM, Silverberg SJ, Standish TI, Syed Z, Syed ZA.

J Clin Endocrinol Metab. 2004 Jul;89(7):3319-25.PMID: 15240609 [PubMed - indexed for MEDLINE]Related articlesFree article

Combination therapy with hormone replacement and alendronate for prevention of bone loss in elderly women: a randomized controlled trial.

Greenspan SL, Resnick NM, Parker RA.

JAMA. 2003 May 21;289(19):2525-33.PMID: 12759324 [PubMed - indexed for MEDLINE]Related articlesFree article

Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.

Hosking D, Chilvers CE, Christiansen C, Ravn P, Wasnich R, Ross P, McClung M, Balske A, Thompson D, Daley M, Yates AJ.

N Engl J Med. 1998 Feb 19;338(8):485-92.PMID: 9443925 [PubMed - indexed for MEDLINE]Related articlesFree article

Bone mineral density response to estrogen replacement in frail elderly women: a randomized controlled trial.

Villareal DT, Binder EF, Williams DB, Schechtman KB, Yarasheski KE, Kohrt WM.

JAMA. 2001 Aug 15;286(7):815-20.PMID: 11497535 [PubMed - indexed for MEDLINE]Related articlesFree article

The effect of the antiestrogen tamoxifen on bone mineral density in normal late postmenopausal women.

Grey AB, Stapleton JP, Evans MC, Tatnell MA, Ames RW, Reid IR.

Am J Med. 1995 Dec;99(6):636-41.PMID: 7503087 [PubMed - indexed for MEDLINE]Related articles

A 3-year study of prevention of postmenopausal bone loss: conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone.

Thiébaud D, Bigler JM, Renteria S, Pache T, Welti HJ, Landry M, Burckhardt P.

Climacteric. 1998 Sep;1(3):202-10.PMID: 11907945 [PubMed - indexed for MEDLINE]Related articles

Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trial.

Greenspan SL, Emkey RD, Bone HG, Weiss SR, Bell NH, Downs RW, McKeever C, Miller SS, Davidson M, Bolognese MA, Mulloy AL, Heyden N, Wu M, Kaur A, Lombardi A.

Ann Intern Med. 2002 Dec 3;137(11):875-83.PMID: 12458987 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of risedronate 5 mg/d on bone mineral density and bone turnover markers in late-postmenopausal women with osteopenia: a multinational, 24-month, randomized, double-blind, placebo-controlled, parallel-group, phase III trial.

Välimäki MJ, Farrerons-Minguella J, Halse J, Kröger H, Maroni M, Mulder H, Muñoz-Torres M, Sääf M, Snorre Øfjord E.

Clin Ther. 2007 Sep;29(9):1937-49.PMID: 18035193 [PubMed - indexed for MEDLINE]Related articles

The effect of low-dose continuous estrogen and progesterone therapy with calcium and vitamin D on bone in elderly women. A randomized, controlled trial.

Recker RR, Davies KM, Dowd RM, Heaney RP.

Ann Intern Med. 1999 Jun 1;130(11):897-904.PMID: 10375338 [PubMed - indexed for MEDLINE]Related articlesFree article

Postmenopausal femur bone loss: effects of a low dose hormone replacement therapy.

Gambacciani M, Ciaponi M, Cappagli B, Monteleone P, Benussi C, Bevilacqua G, Genazzani AR.

Maturitas. 2003 Jul 25;45(3):175-83.PMID: 12818462 [PubMed - indexed for MEDLINE]Related articles

Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

Rapp SR, Espeland MA, Shumaker SA, Henderson VW, Brunner RL, Manson JE, Gass ML, Stefanick ML, Lane DS, Hays J, Johnson KC, Coker LH, Dailey M, Bowen D; WHIMS Investigators.

JAMA. 2003 May 28;289(20):2663-72.PMID: 12771113 [PubMed - indexed for MEDLINE]Related articlesFree article

Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3: a prospective, controlled, randomized study.

Heikkinen AM, Parviainen M, Niskanen L, Komulainen M, Tuppurainen MT, Kröger H, Saarikoski S.

J Clin Endocrinol Metab. 1997 Aug;82(8):2476-82.PMID: 9253321 [PubMed - indexed for MEDLINE]Related articlesFree article